Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

about

Tocilizumab: A Review in Rheumatoid Arthritis.Synergistic effect of interleukin-17 and tumor necrosis factor-α on inflammatory response in hepatocytes through interleukin-6 dependent and independent pathways.

P2860

Q43280791-35AA7502-418D-4F1B-A38C-FD45C7236B4C Q52574737-62412D98-D2C6-46A6-914C-00EC8148DAFC

P2860

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q36396550

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@ast

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@en

type

Item

label

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@ast

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@en

prefLabel

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@ast

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@en

P1476

Transaminase Levels and Hepati ...... Data in Rheumatoid Arthritis.

@en

P2093

Ariella Kelman

http://www.w3.org/2001/XMLSchema#string

Joel M Kremer

http://www.w3.org/2001/XMLSchema#string

Juan Jose Scali

http://www.w3.org/2001/XMLSchema#string

Laura Brockwell

http://www.w3.org/2001/XMLSchema#string

Mark C Genovese

http://www.w3.org/2001/XMLSchema#string

Rieke Alten

http://www.w3.org/2001/XMLSchema#string

Sophie Dimonaco

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

Cytokine pathways and joint inflammation in rheumatoid arthritis.

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Integrated safety in tocilizumab clinical trials.

Interleukin-6 and the acute phase response.

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumato

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.

P31

scholarly article

meta-analysis

P356

10.1002/ART.40176

http://www.w3.org/2001/XMLSchema#string

P50

Ronald van Vollenhoven

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28597609

http://www.w3.org/2001/XMLSchema#string

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

about

P2860

P2860

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698